Commercial
Define the organisation, buying group and operational problem. Explain what the offer can credibly do.
Guide/ 10 min
MedTech ABM Agency & MedTech GTM Agency
MedTech ABM agency guide: how to brief evidence-led ABM for medical device and digital health companies: committee buying, long cycles and regulated claims.
By GTM Quest · Published 17 July 2026 · Updated 10 October 2026 · 10 min read
Your decisionExplore the working brief
Module 01 / 03
Commercial
Define the organisation, buying group and operational problem. Explain what the offer can credibly do.
Module 02 / 03
Evidence
Provide approved technical and use-case material. Keep promotional claims within the evidence your team has reviewed.
Module 03 / 03
Market readiness
Check the applicable jurisdiction and product requirements with the regulatory owner. UK guidance distinguishes Great Britain and Northern Ireland.
GTM Quest editorial guide · Updated 10 October 2026
MedTech account-based marketing and evidence-led market access
Practical guide · 01
Commercial interest and device readiness are different
Marketing activity does not establish that a medical device can be placed on a market. Keep the commercial account plan separate from the regulatory work and refer product-specific questions to the appropriate specialist.
MHRA: regulating medical devices in the UK ↗
Source checked 10 October 2026
Your decision
Evidence
Provide approved technical and use-case material. Keep promotional claims within the evidence your team has reviewed.
Market readiness
Check the applicable jurisdiction and product requirements with the regulatory owner. UK guidance distinguishes Great Britain and Northern Ireland.
Practical guide · 02
One account, several evaluation questions
A MedTech account may involve clinical users, procurement, technical reviewers and budget owners. Build the evidence around their distinct tasks rather than sending one brochure to every role.
- 1
Map
Identify who evaluates use, who checks implementation and who approves commercial terms. Confirm the map in conversations.
- 2
Prepare
Create an approved evidence pack for each task. Separate product documentation from an illustrative business case.
- 3
Coordinate
Assign an account owner and log unresolved questions. A trial discussion is not a procurement commitment.
Practical guide · 03
Worked example: a hospital account evaluates a workflow
Fictional example: a device supplier approaches a hospital. The case is an illustration of account coordination, not a clinical recommendation or a claim of regulatory approval.
- Stage 101
Understand
Ask the users about the current workflow and the organisation about its evaluation route. - Stage 202
Validate
Route clinical, technical and regulatory questions to the qualified owners. Use approved material rather than improvised claims. - Stage 303
Progress
Agree the next evaluation step with the account. Record what remains unresolved before forecasting a deal.
Practical guide · 04
Approve claims before distribution
A marketing workflow must respect the product evidence boundary.
Compare
Material
Use approved product information and substantiated statements.
Questions
Escalate unanswered technical or regulatory questions to qualified owners.
Practical guide · 05
Distinguish user and purchasing authority
Clinical interest does not itself establish buying authority.
Compare
Users
Learn the workflow and evaluation questions.
Procurement
Learn the commercial and institutional decision route.
Practical guide · 06
A pilot needs an agreed purpose
An evaluation should resolve a defined question.
Compare
Before
Agree scope, responsible owners and assessment criteria.
After
Record findings and limitations without inventing efficacy claims.
Practical guide · 07
Keep jurisdiction visible
Market readiness is specific to the product and destination.
Compare
Commercial plan
State where you intend to sell and serve buyers.
Regulatory plan
Have the regulatory owner verify applicable requirements.
Practical guide · 08
Preserve the evidence through the handoff
Account progress should not lose the unanswered questions.
Compare
Context
Record roles, approved material and unresolved issues.
Next step
Agree the evaluation owner and the next decision.
MedTech go-to-market work needs to coordinate clinical users, technical reviewers, procurement and budget owners.
The account plan should make their distinct evaluation questions visible while keeping product claims within the evidence approved by the supplier’s qualified owners.
Account-based marketing can support that coordination where the account value and buying complexity justify the work.
It does not establish product readiness, regulatory compliance or a guaranteed commercial result.
When account-based work is useful in MedTech
- A defined account universe. Identify the health systems, clinics, distributors or other organisations your product can serve. Research relevant accounts rather than assuming every healthcare organisation is a prospect.
- Several evaluation roles. Map who uses the product, who assesses implementation and who approves purchasing. Prepare evidence around their actual questions.
- Useful material before a sales conversation. Provide approved product and implementation explanations buyers can inspect independently. Keep unsupported claims out of outreach and shared content.
- Clear review responsibilities. Account-level targeting does not replace privacy, regulatory or clinical review. Route product-specific questions to qualified owners. For UK market-readiness context, see MHRA medical-device guidance.
What a MedTech GTM engagement should include
- Regulatory-aware messaging: claims mapped to the product’s approved evidence and intended use, with the applicable market requirements checked by the regulatory owner.
- Account universe build: a named list of target health systems, buying centres, and distributors, enriched with signals (tenders, formulary changes, leadership moves, funding).
- Clinical evidence content: white papers, health-economics one-pagers, and KOL-led material that committee members can circulate internally.
- Multi-channel ABM execution: LinkedIn to named accounts, intent monitoring, conference-synced outbound, and nurture built for long cycles.
- Distributor/channel enablement: much of MedTech revenue flows through channel; your GTM system should arm it, not bypass it.
Choosing between a healthcare specialist and a GTM systems agency
Pure healthcare agencies bring regulatory fluency and clinical networks; GTM systems agencies bring modern data infrastructure (Clay, enrichment, intent) and ABM engineering.
The best results usually come from pairing deep clinical review on your side with an agency that can actually build the account-based engine.
Ask any candidate agency: who reviews claims, how they build the account universe, what signals they track, and what happens to the system when the engagement ends.
Related resources
- ABM Agency UK: the UK account-based marketing landscape
- Account-Based Marketing Strategy: the full ABM playbook
- Best GTM Agencies for Healthcare Tech
- Go-to-Market Strategy Agency: how GTM Quest builds 4-channel systems
- GTM Agency Directory
- Enterprise Sales Strategy: committee selling mechanics
If you are weighing up outside help, start with what a go-to-market agency actually does.
If you are in the UK, also see how a London GTM agency like GTM Quest scopes the work before anyone quotes.
01/ questions
FAQ
It depends on scope: the account universe, the channels, and whether paid media and conference support are included.
Ask for a written scope and fee, and weigh it against the value of one extra health-system win.
Agree meaningful evaluation milestones with the account and your sales team.
Track coverage, resolved buying questions and accepted next steps separately from opportunities or revenue.
Timing depends on the product, evaluation route and procurement process; campaign activity does not establish a guaranteed sales deadline.
Have the regulatory owner review the proposed activity, product status and destination market before publication.
Do not infer permission to promote a product from interest in a category.
UK market-readiness requirements are explained in MHRA guidance.
Yes.
We build account-based GTM systems with product claims and market requirements reviewed by the client’s qualified owners for health tech and MedTech scale-ups entering UK and European markets. Book a strategy call.
03/ work with us
Work with GTM Quest
We are a London go-to-market agency. We build the ICP, the positioning and the outbound and ABM system, then run it with you or hand it over.
Our agency
GTM Quest
The GTM agency behind these guides: strategy, systems and pipeline.
ServiceABM agency UK
Account-based marketing for named target accounts.
ServiceB2B demand generation
Creating the interest that outbound converts.
ServiceLead generation
Signal-led outbound that books meetings with your ideal customers.
15 minutes · video or phone
Ready to accelerate your GTM?
Our GTM agency builds revenue engines for B2B SaaS companies with Clay-powered ABM. Tell us your market and stage, and we come back with a written next step, whether or not you work with us.
- 0115 minutes, video or phone
- 02We look at your ICP, positioning and channels
- 03A written next step after the call
- 04Handover, embedded or run-for-you engagements
Pick a day that suits · live availability